TCL Archive Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say May 14, 2010
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive NCS Group Asks DRG Adjustments For Institutions With Peer reviewed Components, 25 Protocol Patients July 1, 1983